Is there a link between oral bacteria and the development of Alzheimer's disease?
There is a consistent association between oral bacteria and Alzheimer's disease, but a proven cause-and-effect relationship in humans has not yet been established. Good oral care is sensible, but do not expect it to offer proven protection against Alzheimer's disease.
P. gingivalis, the key bacterium in gum disease, has been found in the brain tissue of people who died from Alzheimer's disease. A meta-analysis of 16 studies found that when oral bacteria were detectable in the brain, the likelihood of Alzheimer's disease was increased more than tenfold. For P. gingivalis specifically, that figure was approximately sixfold. The toxic enzymes produced by this bacterium (gingipains) correlated with typical Alzheimer-related abnormalities in brain tissue.
Alzheimer's patients also have lower diversity of oral bacteria than people with healthy memory function. This association has been found consistently across multiple clinical studies, but whether gum disease actually causes Alzheimer's disease has not yet been demonstrated in humans. For now, these remain associations, not a proven cause-and-effect relationship.
Animal and laboratory research does provide biologically plausible mechanisms. Repeated exposure to P. gingivalis led in mice to colonisation of the brain, increased production of beta-amyloid (the building block of Alzheimer's plaques), greater inflammation in the brain, and deterioration of cognitive functioning. In cell studies using human brain cells, components of the bacterial cell wall triggered inflammatory responses, amyloid production, and mitochondrial damage. How this travels exactly from the mouth to the brain has not yet been fully clarified; one hypothesis is that small vesicles secreted by the bacterium are able to cross the blood-brain barrier.
Gingipain inhibitors reduced bacterial infection in the brain and protected brain cells in mouse studies. However, in humans with mild to moderate Alzheimer's disease, such an inhibitor had no measurable effect on cognition. That result is a serious caveat regarding the expectation that this therapeutic pathway will work. Whether keeping your oral health in order can prevent Alzheimer's disease is equally unproven in clinical terms. Given the association and the absence of risk, good oral care is worth considering regardless, but it is not a proven form of protection.
Evidence based on a meta-analysis/systematic review (16 studies), multiple reviews, animal and cell studies, and one clinical intervention study with a gingipain inhibitor. Associations are consistent; causality in humans has not been demonstrated.
Is there a relationship between changing body odour and Alzheimer's disease?
Loss of smell is a well-documented early sign of Alzheimer's disease, and changes in body odour are being investigated as a possible marker, but a clinically usable 'smell test' for Alzheimer's disease does not yet exist.
How quickly does the risk of Alzheimer's disease increase as you get older?
The risk of Alzheimer's disease clearly increases with age, but the risk within each age group has remained stable over recent decades. An ageing population is driving the growing number of cases worldwide, which makes factors you can influence all the more relevant.
Is there a treatment in development that prevents Alzheimer's?
There are promising indications that an active lifestyle and treatment of risk factors such as high blood pressure and diabetes can reduce risk. Proven prevention does not yet exist, but starting on those modifiable factors now will in any case yield real health benefits.
Does one egg a week help prevent Alzheimer's disease?
People who eat eggs weekly develop Alzheimer's disease less often in research. Whether eggs themselves cause that difference is uncertain, but one to a few eggs a week fits perfectly within a varied diet.
Is there a link between hormones and the risk of dementia?
Does a lithium deficiency increase the risk of dementia?
Research shows that lithium use is associated with lower rates of dementia, and in people with early memory problems there are initial indications that it may slow cognitive decline. Whether this also applies to advanced dementia remains unclear.